Literature DB >> 7880923

Tumorous manifestation of hairy cell leukemia after long-term treatment with interferon alpha.

D Huhn1, J Oertel, S Serke, D Kaiser, A Schmitt-Gräff, H Stein.   

Abstract

Tumorous-manifestation of hairy cell leukemia in a patient treated with IFN alpha for 7 years is described. After this time, while the patient still was in hematological remission, a tumorous involvement of the lung by hairy cells developed and was successfully treated by surgery. No differences in the phenotype of hairy cells in the lung tumor, in the bone marrow, or in the blood could be detected.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7880923     DOI: 10.1007/bf01834389

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  9 in total

1.  Splenectomy vs. alpha interferon: a randomized study in patients with previously untreated hairy cell leukemia.

Authors:  R V Smalley; J Connors; R L Tuttle; S Anderson; W Robinson; J K Whisnant
Journal:  Am J Hematol       Date:  1992-09       Impact factor: 10.047

2.  Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia.

Authors:  B A Robbins; D J Ellison; J C Spinosa; C A Carey; R J Lukes; S Poppema; A Saven; L D Piro
Journal:  Blood       Date:  1993-08-15       Impact factor: 22.113

3.  Late transition of hairy cell leukemia to multiple myeloma.

Authors:  J Aronowitz; E Baral; B I Dalal
Journal:  Am J Hematol       Date:  1993-11       Impact factor: 10.047

4.  Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment.

Authors:  P Kampmeier; R Spielberger; J Dickstein; R Mick; H Golomb; J W Vardiman
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

Review 5.  Advances in therapy for hairy cell leukemia. A review.

Authors:  I A Jaiyesimi; H M Kantarjian; E H Estey
Journal:  Cancer       Date:  1993-07-01       Impact factor: 6.860

6.  Massive abdominal lymphadenopathy in hairy cell leukaemia: a report of 12 cases.

Authors:  J Mercieca; E Matutes; E Moskovic; K MacLennan; F Matthey; C Costello; J Behrens; S Basu; S Roath; S Fairhead
Journal:  Br J Haematol       Date:  1992-11       Impact factor: 6.998

7.  Hairy cell leukemia: a tumor of pre-plasma cells.

Authors:  K C Anderson; A W Boyd; D C Fisher; D Leslie; S F Schlossman; L M Nadler
Journal:  Blood       Date:  1985-03       Impact factor: 22.113

Review 8.  Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy.

Authors:  S Vedantham; H Gamliel; H M Golomb
Journal:  Cancer Res       Date:  1992-03-01       Impact factor: 12.701

9.  Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.

Authors:  J W Smith; D L Longo; W J Urba; J W Clark; T Watson; J Beveridge; K C Conlon; M Sznol; S P Creekmore; W G Alvord
Journal:  Blood       Date:  1991-10-01       Impact factor: 22.113

  9 in total
  1 in total

Review 1.  Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece.

Authors:  E Campo; A Chott; M C Kinney; L Leoncini; C J L M Meijer; C S Papadimitriou; M A Piris; H Stein; S H Swerdlow
Journal:  Histopathology       Date:  2006-04       Impact factor: 5.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.